George Hlass is the Senior Director of Business Development for Active Pharmaceutical Ingredients (APIs) at Fareva. He has 20 years of experience in the pharmaceutical and biotech industries and has been the head of business development in North America for Fareva’s drug substance business for the past eight years. Previously, he worked for 10 years at two other chemistry-focused contract development and manufacturing organizations (CDMOs) that offered services in discovery, development and commercial manufacturing of small molecule APIs. He began his career in biotechnology, with three years of experience in the field of gene therapy.
.svg)
